Chronic Myeloid Leukemia: Understanding Loss of Response

0 Views
administrator
administrator
07/08/23

Harry P. Erba, MD; Jorge E. Cortes, MD; and Michael Mauro, MD, provide their perspective on loss of response and mechanisms of resistance as they pertain to switching therapy with BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next